Latest medical news: Is it necessary to take ixazomib long-term?

Ixazomib is an oral proteasome inhibitor indicated for use in combination with lenalidomide and dexamethasone in patients with multiple myeloma who have received at least one prior therapy. Multiple myeloma is a chronic disease that requires long-term treatment and management, so the use of ixazomib is usually long-term, and the specific medication regimen should be determined by the doctor based on the patient's condition.

Generally speaking, ixazomib needs to be taken regularly according to the doctor's recommendations and for a certain period of time to maintain tumor control. Treatment of multiple myeloma is a long-term process, and it takes a period of time to observe the effects of treatment. During the treatment process, doctors will adjust the medication plan based on factors such as the patient's condition, tolerance, and treatment response. However, long-term use of ixazomib may cause some side effects and adverse reactions, such as nausea, vomiting, diarrhea, constipation, anemia, thrombocytopenia, etc. Therefore, when using ixazomib, you need to follow the doctor's instructions and pay attention to controlling the dosage and time of use to avoid adverse reactions.

The original drug of Ixazomib has been launched in China and is included in Class B medical insurance. The price of common capsule preparations may be more than 10,000 yuan per box, which is relatively expensive. The price of the original drug of ixazomib sold overseas is more than 10,000 US dollars per box (the price may fluctuate due to the exchange rate). Ixazomib Generic drugs are also produced and sold overseas, and their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 4mg*3 tablets produced by a Laos pharmaceutical factory may be less than 1,000 yuan per box (the price may fluctuate due to the exchange rate), and the price is relatively cheap.